Back to
UBS Group AG
CABA
Showing 8 of 25 quarters
Position history for
UBS Group AG's holdings in Cabaletta Bio, Inc.
Yes. UBS Group holds 1,471,895 shares of CABA (Cabaletta Bio), worth $4.6M, as of its Q2 2026 13F filing. It increased the position by 865,231 shares (+142.6%) from Q1 2026. UBS Group has held CABA since Q3 2022, across 16 quarterly 13F filings.
Current Value
$4.6M
Current Shares
1.5M
Total Value Change
+$4.5M
Total Shares Change
+1.4M
Quarter-by-Quarter History